Home / Private raises / Graviton BioScience Corp

Graviton BioScience Corp

Biotechnology · New York, New York · $5.0M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-16D (new)$5.0M$75.0M2506(b)EquityOct 23SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryBiotechnology
LocatedNew York, New York
EntityCorporation
IncorporatedDelaware
SEC CIK1847048

People named in the latest filing

NameRole
Samuel D WaksalExecutive Officer, Director, Promoter
Rui WuExecutive Officer
David MacMillanDirector
Ran NussbaumDirector
James BoylanDirector
Dixon BoardmanDirector
Michael BaranDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?